Skip to main content

Site notifications

Updates to listed medicine ingredients

Updates to the Therapeutic Goods (Permissible Ingredients) Determination

Updates to listed medicine ingredients occur quarterly at minimum. Notices regarding updates to listed medicine ingredients are shown in this collection.

Use the filters below to narrow your search.

Filter results

You can narrow down the results using the filters.

Read more about Changes to the Permissible Ingredients Determination.

The Therapeutic Goods (Permissible Ingredients) Determination contains the current list of permissible ingredients for listed medicines.

Collection content

34 result(s) found, displaying 1 to 10
  • Listed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 4) 2025, which commenced on 10 December 2025.
  • Compositional guideline for Urolithin A permitted for use in listed medicines.
  • Compositional guideline for Pediococcus pentosaceus CECT 8330 permitted for use in listed medicines.
  • Listed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 3) 2025, which commenced on 19 September 2025.
  • Compositional guideline for Nicotinamide mononucleotide permitted for use in listed medicines.
  • Compositional Guideline: Stearoyl Glutamic Acid permitted for use in listed medicines.
  • Compositional guideline Sorbitan Distearate permitted for use in listed medicines.
  • Listed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 2) 2025, which commenced on 20 June 2025.